Home › Myriad Genetics (MYGN) Forecasted to Post Q1 2017 Earnings of $0.45 Per Share
 

Keywords :   


Myriad Genetics (MYGN) Forecasted to Post Q1 2017 Earnings of $0.45 Per Share

2015-11-07 07:41:57| Biotech - Topix.net

Investment analysts at Jefferies Group cut their Q1 2017 earnings per share estimates for shares of Myriad Genetics in a research note issued on Wednesday, according to Zacks Investment Research . Jefferies Group analyst B. Couillard now forecasts that the firm will earn $0.45 per share for the quarter, down from their prior estimate of $0.46.

Tags: post share earnings genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Mortgage costs 'biggest challenge' for homeowners
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Public Advisory Number 26A
05.07Atlantic Tropical Weather Outlook
05.07Eastern North Pacific Tropical Weather Outlook
05.07Samsung expects profits to jump by more than 1,400%
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 26
More »